Bridging Tumor Genomics to Patient Outcomes through an Integrated Patient-Derived Xenograft (PDX) Platform

New approaches to optimizing cancer drug development in both the laboratory and the clinic will be required to fully achieve the goal of individualized, precision cancer therapy. Improved preclinical models that more closely reflect the now recognized genomic complexity of human cancers are needed....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Lung Cancer
Main Authors: Gandara, David R., Mack, Philip. C., Bult, Carol, Li, Tianhong, Lara, Primo N., Riess, Jonathan W., Astrow, Stephanie H., Gandour-Edwards, Regina, Cooke, David T., Yoneda, Ken Y., Moore, Elizabeth H., Pan, Chong-xian, Burich, Rebekah A., David, Elizabeth A., Keck, James G., Airhart, Susan, de Vere White, Ralph W., Liu, Edison T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4586173/
https://ncbi.nlm.nih.gov/pubmed/25838158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2015.03.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados